Acid anhydrides such as methyltetrahydrophthalic anhydride (MTHPA) are widely used in the production of alkyd and polyester resins and as curing agents for epoxy resins. These substances are known as potent lowmolecular allergens and induce predominantly type I allergies 1) . Therefore, safe use in industry demands control of the levels of exposure causing allergic diseases, including asthma, in the workshop. In the field of sensitizing agents, recommendations or guidelines appear to be few; for example, the American Conference of Governmental Industrial Hygienists (ACGIH) has only recommended exposure limits for some acid anhydrides such as acetic anhydride, maleic anhydride (MA), phthalic anhydride (PA), and trimellitic anhydride (TMA) 2) . Moreover, these control limits apply to irritancy rather than to allergy, except TMA; accordingly, the level of exposure to acid anhydrides should be kept as low as possible below these values.
In surveillance studies of subjects exposed to acid anhydrides, the most important risk factor for the development of antibody and immunologically mediated disease is the exposure level [3] [4] [5] [6] [7] . To date, information on exposure-response relations has been limited. The purpose of this study was therefore to examine the relation between exposure to MTHPA and the occurrence of workrelated eye and nasal symptoms in a condenser plant. In occupational medicine, this approach enables us to offer further protection from allergic disorders due to MTHPA.
Subjects and Methods
Production: The plant that was investigated manufactures condensers for electric appliances. Continuous production started in 1982. MTHPA is used as a hardener in an epoxy resin system for electric insulation and protection. After the condensers are assembled automatically (zones 1 and 2), a small amount of epoxy resin mixture is poured into them. They pass through a curing oven at a temperature of 100°C (zone 3). After curing, the condensers are tested electrically (zone 4). The main exposure originates from the curing ovens. It was found that air moved from zone 3 to other zones in the workshop.
Subjects and medical examination: During December 1994 to February 1995, 73 present and 22 former workers were studied to evaluate some risk factors for sensitization and described in detail in a previous paper 8) . The participation rate for workers with current exposure was 97%. They consisted of 45 continuously and 28 intermittently exposed workers. During the same period we also conducted a 1-week cross-sectional survey of the 45 continuously exposed workers to relate MTHPA exposure to clinical outcomes.
In relation to our previous study 8) , smoking habits and occupational history were recorded, and the atopic status was assessed by history. Work-related eye and nasal symptoms were defined as attacks of pruritus, congestion, or lacrimation of the eyes or of sneezing, secretion, or blockage, recovering either over the weekends or during holidays and starting after the first exposure to MTHPA. A physical examination was done by an occupational physician (KY), and then venous blood samples were collected for analysis of specific IgE antibodies to MTHPA.
Exposure measurements: The exposure measurements were performed according to a procedure which has previously been described 8) . Briefly, MTHPA vapors were collected on silica-gel tubes by area sampling with battery-operated pumps, and the sampling of MTHPA in air was performed at the center of each zone in the afternoon. The sampled MTHPA were analyzed by gas chromatography with flame ionization detector after derivatization. Exposure to MTHPA was measured during this survey, but stationary air-sampling in zone 3 was not carried out on 2 consecutive days, as the conditions of exposure had changed during the repair of partitions.
Symptom evaluation: In addition to the working environment measurements, nasal symptoms were recorded after the workers had finished for the day. Sneezing, secretion and blockage were each rated on a scale of 0-3 (no symptoms=0, mild=1, moderate=2, and severe=3). The ratings were performed by the workers themselves and confirmed by a plant nurse. Furthermore, a composite nasal symptom score was calculated by adding the score for sneezing, secretion and blockage. Similarly, eye symptoms (pruritus, congestion and lacrimation) were also recorded and a composite eye symptom score was calculated. It should be emphasized that all were subjective responses on the part of the workers.
Serologic analysis: Pharmacia (Pharmacia Diagnostics AB, Uppsala, Sweden) provided immunocapsules made of hydrophilic polymer to which an MTHPA human serum albumin conjugate was fixed. Specific IgE levels were measured by means of a Pharmacia CAP system. Specific IgE values exceeding 0.35 U/ml were considered positive.
Statistical analysis: Differences were tested by ANOVA, chi-square test, or Fisher's exact test. A Pvalue less than 0.05 was considered statistically significant. All analyses were performed with the SPSS computer program 9) .
Results and Discussion
The 45 subjects (28 female and 17 male) were engaged in monitoring work in the various work zones, did not change job categories, and were continuously exposed during an 8-h work shift (8-421 µg/m 3 in 1993-1995) 8) . Twenty-six (57.8%) of the subjects were sensitized to MTHPA: of those, 20 workers suffered from work-related symptoms (group SS) and six workers did not complain of work-related symptoms (group SN). It is unlikely that the high sensitization rate is due to selection bias, since the participation rate was adequate. Because of the high frequency of positive specific IgE, as explained previously 8) , it is possible that airborne MTHPA concentrations were higher before the time of the investigation and that the high frequency we found mainly reflected previous exposure. On the basis of the present data, therefore, an association of the intensity of MTHPA exposure with sensitization cannot be argued. Another study on workers exposed to MTHPA 10) showed a sensitization rate of 16% even at exposures below 20 µg/ m 3 . These results demonstrate that MTHPA, like the other acid anhydrides, has a sensitizing ability. On the other hand, the other 19 workers showed no signs of sensitization. Three of them complained of work-related symptoms (group NS). The remaining 16 workers displayed no work-related symptoms (group NN). There were no statistically significant differences in gender, age, exposure time, smoking status or atopic history among the groups (data not shown).
It is important that these effects of MTHPA be prevented by controlling the level of exposure in the workshop. For MTHPA, neither in Japan, in the USA, nor in Germany is there an occupational exposure limit. MTHPA closely resembles PA in its chemical structure. Based on the irritancy of PA relative to MA, a Threshold Limit Value-Time Weighted Average (TLV-TWA) of 6.1 mg/m 3 has been recommended since 1976 2) . Due to the sensitizing properties of PA, its MAK value (maximum workplace concentration) was decreased in 1992 from 5 to 1 mg/m 3 11) . Likewise, the Japan Society for Occupational Health (JSOH) established an Occupational Exposure Limit-Ceiling (OEL-C) of 2 mg/m 3 in 1998 12) . As shown in Table 1 , workplace air MTHPA concentrations varied in the manufacturing processes within a range of 20.4-144 µg/m 3 and were considerably lower than the PA control limits, so that the irritant effect of MTHPA seems not to be relevant for the very low exposure levels reported.
Sensitization to MTHPA was significantly (P<0.0001) associated with work-related eye and nasal symptoms, indicating that the work-related symptoms were caused by an IgE-mediated allergy, but not all subjects who developed IgE antibody manifested work-related symptoms. It is well recognized that development of either IgE or IgG antibody to a variety of occupational antigens is not necessarily associated with disease 3, [13] [14] [15] [16] . On the other hand, it is possible that the sensitized nonsymptomatic (SN) group will develop allergic symptoms due to MTHPA exposure in the near future. Close monitoring of exposed subjects with significant antibody seems prudent. By contrast, the mechanism behind the symptoms in the nonsensitized symptomatic (NS) group is unclear. They may have been elicited by some other nonallergic mechanism. Alternatively, other exposures, for instance to epoxy resin, might have caused the work-related symptoms, as airways allergy to epoxy resin has been reported 17) . Further studies, including challenge tests with the substances involved, are necessary to clarify this matter.
The clinical follow-up data on the symptomatic workers are listed in Table 2 . Symptoms affected mainly the nose and eyes; no symptoms suggestive of asthma were found in the exposed workers. As we mentioned in the previous paper 8) , this result may reflect the very low exposure levels in recent years. Alternatively, a healthy worker selection may have occurred, since our study was cross-sectional. Fifteen workers suffered from workrelated rhinoconjunctivitis and 8 workers from workrelated rhinitis. Most of these symptoms appeared from the beginning of the week, continued during the week, and subsided completely on the weekend. In zone 1, the MTHPA concentrations decreased from 44-143 µg/m 3 on Monday-Tuesday to 20.4-23.6 µg/m 3 on Wednesday-Friday, but the exposure to lower concentrations could not result in a dramatic decrease in the number of symptomatic workers, although worker 4 became symptomless. For the severity of the symptoms, each subject was classified into one of the following categories: "mild" (score=1-3), "moderate" (score=4, 5), and "severe" (score=6 or higher). The eye symptoms were generally of mild or moderate intensity, while the severity of the nasal symptoms were usually moderate or severe. It is thought that depending on individual disposition, allergic reactions can be induced by MTHPA in differing degrees of severity after sensitization.
Allergic rhinitis is not considered to be as serious as asthma, but it can be troublesome for many symptomatic workers, since it can cause considerable impairment of health-related quality of life 18) . Indeed 15 (75%) of the workers from the SS group continued to be very symptomatic after they returned home; 10 (50%) were receiving medication for rhinitis. On the basis of the present data (Tables 1 and 2) , the minimal concentration of MTHPA in air that was associated with the work-related symptoms was 20.4 to 23.6 µg/m 3 . This concentration is extremely low and is comparable with the TLV value for TMA (40 µg/m 3 ) 2) . Increased responsiveness to the upper airways of MTHPA may occur after sensitization. The present results are consistent with the result from two condenser plants that used MTHPA 19) , where a geometric mean concentration of >25 µg/m 3 was found to be significantly (odds ratio 16.9) associated with workrelated rhinitis. Additionally, allergic rhinitis seems to precede occupationally incurred asthma 20) , suggesting that prevention of rhinitis and improvements in nasal symptoms may protect workers from the significant risk of asthma. An OEL for MTHPA should therefore be based on the incidence of occupational rhinitis in defined workforces. In a 1999 report, we have advised that MTHPA exposure at levels above 15 µg/m 3 should be avoided to prevent the development of occupational allergic diseases in most sensitized workers 19) . The levels of exposure that elicit symptoms in sensitized individuals are different from those sufficient to induce the sensitized state in unsensitized persons. Nevertheless, this value may also protect workers from the significant risk of sensitization, since a 1990 report by Welinder et al. described a decreased frequency of sensitization in a group of 23 workers exposed to a mean MTHPA concentration of 10 (7-14) µg/m 3 when compared with a group of 54 workers exposed to a mean MTHPA concentration of 85 (7-380) µg/m 3 (9% and 22%, respectively) 6) .
In conclusion, MTHPA causes both rhinitis and conjunctivitis at extremely low atmospheric concentrations, at or below 23.6 µg/m 3 . The present data and our series of reports 8, 19) can be used to develop exposure reduction strategies and give firm support to the establishment of an OEL for MTHPA.
